hemophilia

Roche culls ph. 3 Spark gene therapy in hemophilia

After the elimination of a gene therapy study last week, Roche confirmed that it’s axing a hemophilia candidate from its buyout of Spark Therapeutics.

Fraiser Kansteiner Dec 16, 2024 12:24pm

Centessa drops hemophilia B drug following Pfizer’s Hympavzi win

Nov 12, 2024 9:45am

Graphic of a drop of blood made up of small data points and nodes

Pfizer gene therapy reduces bleeds in ph. 3 hemophilia A trial

Jul 24, 2024 8:44am

Novo unwraps phase 3 data on rival to Roche in hemophilia A

Jun 24, 2024 5:26am

showdown clash versus vs crash lightning fight dispute

Novo Nordisk's Hemlibra rival hits goals in phase 3

May 14, 2024 9:16am

triathlon challenge crowded busy swim water competition race

ASH: Pfizer swims in crowded sickle cell, hemophilia waters

Dec 9, 2023 7:00pm